Department of Medicine II, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Clincial Cooperation Unit Healthy Metabolism, Center for Preventive Medicine Baden-Württemberg, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
BMC Infect Dis. 2021 Jun 26;21(1):612. doi: 10.1186/s12879-021-06294-2.
The unexpected outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused more than 49 million cases and an estimated 2,000,000 associated deaths worldwide. In Germany, there are currently more than 2,000,000 laboratory-confirmed coronavirus disease 2019 (COVID-19) cases including 51,800 deaths. However, regional differences also became apparent and with the second wave of infections, the detailed characterization of COVID-19 patients is crucial to early diagnosis and disruption of chains of infections.
Handing out detailed questionnaires to all individuals tested for COVID-19, we evaluated the clinical characteristics of negative and positive tested individuals. Expression of symptoms, symptom duration and association between predictor variables (i.e. age, gender) and a binary outcome (olfactory and gustatory dysfunction) were assessed.
Overall, the most common symptoms among individuals who tested positive for SARS-CoV-2 were fatigue, headache, and cough. Olfactory and gustatory dysfunction were also reported by many SARS-CoV-2 negative individuals, more than 20% of SARS-CoV-2 negative tested individuals in our study reported olfactory and gustatory dysfunction. Independent of SARS-CoV-2 status, more females displayed symptoms of gustatory (29.8%, p = 0.0041) and olfactory dysfunction (22.9%, p = 0.0174) compared to men.
Bringing early SARS-CoV-2 tests to the populations at risk must be a main focus for the upcoming months. The reliability of olfactory and gustatory dysfunction in COVID-19 negative tested individuals requires deeper investigation in the future.
新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的意外爆发在全球范围内导致超过 4900 万例病例和估计 200 万例相关死亡。在德国,目前有超过 200 万例经实验室确认的 2019 年冠状病毒病(COVID-19)病例,包括 51800 例死亡。然而,地区差异也变得明显,随着第二波感染,对 COVID-19 患者的详细特征描述对于早期诊断和阻断感染链至关重要。
向所有接受 COVID-19 检测的个体发放详细问卷,我们评估了检测结果为阴性和阳性个体的临床特征。评估了症状的表现、症状持续时间以及预测变量(即年龄、性别)与二项结局(嗅觉和味觉功能障碍)之间的关系。
总体而言,检测结果为 SARS-CoV-2 阳性的个体最常见的症状是疲劳、头痛和咳嗽。嗅觉和味觉功能障碍也被许多 SARS-CoV-2 阴性个体报告,在我们的研究中,超过 20%的 SARS-CoV-2 阴性检测个体报告了嗅觉和味觉功能障碍。无论 SARS-CoV-2 状态如何,女性出现味觉(29.8%,p=0.0041)和嗅觉(22.9%,p=0.0174)功能障碍的症状均多于男性。
在未来几个月,必须将早期 SARS-CoV-2 检测带给高危人群,作为主要重点。COVID-19 阴性检测个体中嗅觉和味觉功能障碍的可靠性需要在未来进行更深入的研究。